** Brokerage Morgan Stanley starts coverage on hospital operator Tenet Healthcare THC.N with "overweight" rating and $165 PT
** New PT represents 26.2% upside to the stock's last close
** Brokerage says significant changes in business model and balance sheet not yet reflected in THC's stock price
** Brokerage believes co is well-positioned to benefit from the shift towards outpatient care as outpatient visits have grown ~30% from 2000 to 2022, driven by technological enhancements, reimbursement changes and consumer preferences
** Notes THC's key growth areas include orthopedics, urology, cardiology, GI and cancer
** Including session moves, THC stock up 4.5% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。